Symptom Severity Following Rifaximin and the Probiotic VSL#3 in Patients with Chronic Pelvic Pain Syndrome (Due to Inflammatory Prostatitis) Plus Irritable Bowel Syndrome.
about
Symptom Severity Following Rifaximin and the Probiotic VSL#3 in Patients with Chronic Pelvic Pain Syndrome (Due to Inflammatory Prostatitis) Plus Irritable Bowel Syndrome.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Symptom Severity Following Rif ...... Plus Irritable Bowel Syndrome.
@en
Symptom Severity Following Rif ...... h Chronic Pelvic Pain Syndrome
@nl
type
label
Symptom Severity Following Rif ...... Plus Irritable Bowel Syndrome.
@en
Symptom Severity Following Rif ...... h Chronic Pelvic Pain Syndrome
@nl
prefLabel
Symptom Severity Following Rif ...... Plus Irritable Bowel Syndrome.
@en
Symptom Severity Following Rif ...... h Chronic Pelvic Pain Syndrome
@nl
P2093
P2860
P356
P1433
P1476
Symptom Severity Following Rif ...... Plus Irritable Bowel Syndrome.
@en
P2093
Giuseppe Sidoti
Mariano Malaguarnera
Roberto Castiglione
P2860
P356
10.3390/NU9111208
P577
2017-11-03T00:00:00Z